| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |